Skip to content

OMass Therapeutics vs Quantum-Si

OMass Therapeutics logo

OMass Therapeutics

OMass Therapeutics uses high-resolution mass spectrometry to discover drugs, targeting complicated medical needs, backed by Syncona and Oxford Science Enterprises

74 employees · est. 2016 · Oxford, United Kingdom

VS
Quantum-Si logo

Quantum-Si

The Protein Sequencing Company™

166 employees · est. 2013 · Branford, United States

Quantum-Si is the older company (2016 vs 2013).

Side-by-Side Comparison

OMass Therapeutics Quantum-Si
Founded
2016 2013 older
Headquarters
Oxford, United Kingdom Branford, United States
Employees
74 166
Industry
Life Sciences, Pharmaceutical Biotechnology, Health Care, Life Sciences
Funding Stage
Series B IPO
Total Funding
$128.00M $215.00M
Funding Rounds
5 5
Services
Proprietary biochemistry solutions, Native mass spectrometry integration, Custom chemistry applications Single-molecule Protein Sequencing, Protein Barcoding, Antibody Sequencing and Characterization, Protein Variant Analysis, PTM (Post-translational Modification) Analysis
Target Customers
Biotechnology researchers, Pharmaceutical companies, Academic institutions Research Laboratories, Biotechnology Companies, Pharmaceutical Companies, Academic Institutions, Clinical Proteomics Researchers
Taxonomy
High-Resolution Mass SpectrometryDrug DiscoveryPharmaceuticalsStructural Mass SpectrometryProtein AssembliesMembrane Receptors +6 ProteomicsProtein SequencingSingle-Molecule AnalysisKinetic-Based DetectionBenchtop PlatformDrug Discovery +9
Website
omass.com quantum-si.com
OMass Therapeutics logo

About OMass Therapeutics

OMass Therapeutics, founded in 2016 and headquartered in the United Kingdom, stands at the forefront of pharmaceutical innovation, emphasizing its prowess in Life Sciences and Pharmaceutical industries. Harnessing high-resolution mass spectrometry, the company aims to address complex medical needs b...

Quantum-Si logo

About Quantum-Si

Quantum-Si, known as The Protein Sequencing Company™, is revolutionizing the field of proteomics by offering a benchtop platform for single-molecule protein analysis. Founded in 2013, the United States-based company empowers researchers to bypass traditional, cumbersome workflows and directly obtain...

Also comparing in this category

Comparing more than these two?

Get OMass Therapeutics, Quantum-Si and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does OMass Therapeutics compare?

A PDF of OMass Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

OMass Therapeutics was founded in 2016, based in Oxford, United Kingdom, with 74 employees. OMass Therapeutics, founded in 2016 and headquartered in the United Kingdom, stands at the forefront of pharmaceutical innovation, emphasizing its prowess in Life Sciences and Pharmaceutical industrie. Quantum-Si was founded in 2013, based in Branford, United States, with 166 employees. Quantum-Si, known as The Protein Sequencing Company™, is revolutionizing the field of proteomics by offering a benchtop platform for single-molecule protein analysis. Founded in 2013, the United State.
OMass Therapeutics has raised $128.00M and Quantum-Si $215.00M. Latest stage: OMass Therapeutics Series B, Quantum-Si IPO.
Both work in Life Sciences and Pharmaceutical and list drug discovery among their focus areas.

Compare OMass Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at OMass Therapeutics on 11 Mar 2026, and Quantum-Si on 8 Nov 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout